Book Description
FDA Orange Book 31st Edition - 2011 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author : Food and Drug Administration
Publisher : DrugPatentWatch.com
Page : 1253 pages
File Size : 45,19 MB
Release : 2011
Category : Medical
ISBN : 193489981X
FDA Orange Book 31st Edition - 2011 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author : Food and Drug Administration
Publisher : DrugPatentWatch.com
Page : 1299 pages
File Size : 25,37 MB
Release : 2012
Category : Medical
ISBN : 1934899828
FDA Orange Book 32nd Edition - 2012 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author : Food and Drug Administration
Publisher : DrugPatentWatch.com
Page : 1161 pages
File Size : 25,62 MB
Release : 2009
Category : Medical
ISBN : 1934899798
FDA Orange Book 29th Edition - 2009 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author : DrugPatentWatch
Publisher : DrugPatentWatch.com
Page : 100 pages
File Size : 46,71 MB
Release : 2023-08-15
Category : Medical
ISBN : 1934899852
This report focuses on NESINA and covers the following critical aspects of this drug:
Author : DrugPatentWatch
Publisher : DrugPatentWatch.com
Page : 101 pages
File Size : 42,89 MB
Release : 2023-08-15
Category : Medical
ISBN : 1934899836
This report focuses on MOVIPREP and covers the following critical aspects of this drug:
Author : Food and Drug Administration
Publisher : DrugPatentWatch.com
Page : 1115 pages
File Size : 43,45 MB
Release : 2010
Category : Medical
ISBN : 1934899801
FDA Orange Book 30th Edition - 2010 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author : Food and Drug Administration
Publisher : DrugPatentWatch.com
Page : 1039 pages
File Size : 25,13 MB
Release : 2005
Category : Medical
ISBN : 1934899755
FDA Orange Book 25th Edition - 2005 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author : Markham C. Luke
Publisher : Elsevier Health Sciences
Page : 121 pages
File Size : 11,85 MB
Release : 2022-06-24
Category : Medical
ISBN : 0323849709
In this issue, guest editors bring their considerable expertise to this important topic.Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Author : David B. Young
Publisher : Springer Science & Business Media
Page : 299 pages
File Size : 49,4 MB
Release : 2013-03-08
Category : Medical
ISBN : 1468460366
This book represents the invited presentations and some of the posters presented at the conference entitled "In Vitro-In Vivo Relationship (IVIVR) Workshop" held in Sep tember, 1996. The workshop was organized by the IVIVR Cooperative Working Group which has drawn together scientists from a number of organizations and institutions, both academic and industrial. In addition to Elan Corporation, which is a drug delivery com pany specializing in the development of ER (Extended Release) dosage forms, the IVIVR Cooperative Working Group consists of collaborators from the University of Maryland at Baltimore, University College Dublin, Trinity College Dublin, and the University of Not tingham in the UK. The principal collaborators are: Dr. Jackie Butler, Elan Corporation Prof. Owen Corrigan, Trinity College Dublin Dr. lain Cumming, Elan Corporation Dr. John Devane, Elan Corporation Dr. Adrian Dunne, University College Dublin Dr. Stuart Madden, Elan Corporation Dr. Colin Melia, University of Nottingham Mr. Tom O'Hara, Elan Corporation Dr. Deborah Piscitelli, University of Maryland at Baltimore Dr. Araz Raoof, Elan Corporation Mr. Paul Stark, Elan Corporation Dr. David Young, University of Maryland at Baltimore The purpose of the workshop was to discuss new concepts and methods in the devel opment of in vitro-in vivo relationships for ER products. The original idea went back ap proximately 15 months prior to the workshop itself. For some time, the principal collaborators had been working together on various aspects of dosage form development.
Author : OECD
Publisher : OECD Publishing
Page : 12 pages
File Size : 33,39 MB
Release : 1997-07-21
Category :
ISBN : 9264071245
The bacterial reverse mutation test uses amino-acid requiring at least five strains of Salmonella typhimurium and Escherichia coli to detect point mutations by base substitutions or frameshifts. The principle of this bacterial reverse mutation test ...